Skip to content

Methylation analysis for soft tissue lesions and rapid classification

Nanopore-based methylome classification and next-day comprehensive tumour profiling for ultra-rapid tumour diagnostics in soft-tissue sarcomas

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN52235823
Enrollment
50
Registered
2025-05-21
Start date
2025-06-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis of sarcoma in adults Cancer

Interventions

Participants will have one tissue sample collected, either from an additional core biopsy taken at the time of diagnosis, or via sampling of the surgically resected lesion at the time of its excision.

Sponsors

University of Nottingham
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Considered to have sarcomatous soft-tissue lesion requiring biopsy or surgical excision 2. A good comprehension of the English language 3. Age =18 years old 4. Ability to give informed consent

Exclusion criteria

Exclusion criteria: 1. Patients in which the usual care team believe the lesion to have low risk of malignancy (i.e., most likely a benign lesion based on clinical history, examination and investigation findings)

Design outcomes

Primary

MeasureTime frame
Percentage of sarcoma diagnoses correctly predicted by methylation-based classification, at 12 months post-biopsy or surgery

Secondary

MeasureTime frame
Percentage of sarcomas in which known pathognomonic molecular features are correctly identified by nanopore long-read sequencing, at 12 months post-biopsy or surgery

Countries

England, United Kingdom

Contacts

Public ContactChristopher Deacon
christopher.deacon@nottingham.ac.uk+44 115 82 31113

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 3, 2026